VeriChip Corporation Granted Exclusive License to Patents Used in Virus Triage Detection System for H1N1 Virus – Virus triage detection system being developed in conjunction with partner, RECEPTORS, will help process patient samples DELRAY BEACH, FL and CHASKA, MN — VeriChip Corporation (“VeriChip”) (NASDAQ: CHIP) and its development partner RECEPTORS LLC, a technology company whose […]
Exiqon A/S (NASDAQ OMX Copenhagen: “EXQ”) today announced the successful completion of several key milestones in a custom-designed RNAi project for Tacere Therapeutics. San Jose and Copenhagen (PRWEB) — Exiqon A/S (https://www.exiqon.com/ls) (NASDAQ OMX Copenhagen: “EXQ”) today announced the successful completion of several key milestones in a custom-designed RNAi project for Tacere Therapeutics. This project […]
Expanded IP portfolio includes rapidly growing HRM applications for all markets and applications Venlo, The Netherlands — QIAGEN (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA), today announced that it has acquired additional licenses from Roche (SIX: RO, ROG; OTCQX: RHHBY) and Idaho Technology related to the use of instrumentation and reagents for PCR-based molecular testing. Financial […]
Meridian Bioscience Granted Special 510(k) Clearance to Add 2009 H1N1 Influenza A Virus Analytical Sensitivity Claim to the TRU FLU® Test Package Insert CINCINNATI–Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ:VIVO) today announced that the company has been granted a Special 510(k) clearance to update the TRU FLU package insert to include analytical sensitivity claims with two […]
First Commercial Test from Sequenom Center for Molecular Medicine SAN DIEGO — SEQUENOM, Inc. (Nasdaq: SQNM – News) today announced that the company’s first laboratory developed test, the SensiGene(TM) Cystic Fibrosis (CF) Carrier Screening test, has been launched. This test is available exclusively through the Sequenom Center for Molecular Medicine, a next-generation CLIA (Clinical Laboratory […]
Dionex Enters Into Agreement With ESA Biosciences to Acquire the Assets of ESA Life Sciences Tools Business Unit SUNNYVALE, Calif. — Dionex Corporation (Nasdaq:DNEX), a leading provider of innovative liquid chromatography analysis systems, has entered into an Asset Purchase Agreement with ESA Biosciences, a wholly owned subsidiary of Magellan Biosciences, Inc., to purchase ESA Biosciences […]
MUKILTEO, Wash. — CombiMatrix Corporation (Nasdaq:CBMX – News) announced today that it has engaged Robert W. Baird & Co. (Baird) to serve as a financial and strategic advisor. Baird will aid CombiMatrix in developing and reviewing certain strategies aimed at unlocking shareholder value and creating synergistic relationships for CombiMatrix. Dr. Amit Kumar, President and CEO […]
Abbott Park, Illinois — Abbott announced today it has been named the overall Gold winner of the 2009 Wall Street Journal Technology Innovation Awards for its Ibis T5000 Biosensor system, which is designed to detect and characterize a broad range of infectious agents in a given sample, including viruses, bacteria and fungi. “Abbott is dedicated […]
Roka Bioscience to Develop Rapid, Accurate Molecular Tests for Biopharmaceutical Production Processes, Water and Food Testing, and Other Fields – Transaction Enables Gen-Probe to Focus on Human Diagnostic Opportunities SAN DIEGO — Gen-Probe Incorporated (Nasdaq: GPRO) announced today that it is spinning off its industrial testing assets into a new, independent company focused on developing […]
New Test Complements Company’s Broad Menu of Solutions for Surveillance of Swine Flu Infections used by Health Authorities Worldwide VENLO, The Netherlands & DALIAN, China–QIAGEN (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA), today announced both the launch of a new Influenza A/H1N1 test and several updates to its activities in providing solutions for the global surveillance […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
